Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Variability in Killler Immunglobulin like Receptor Gene Expression As a Periodic Function of Gene Position on Chromosome 19

Elizabeth Krieger, MD, Urmila Sivagnanaling, Katherine Webb, Rehan Qayyum, MD, Amir Ahmed Toor, MBBS

Blood (2019) 134 (Supplement_1): 3608.

https://doi.org/10.1182/blood-2019-132270

Published: 2019

Journal Articles

Identification of a Gene Signature Associated to Treatment Response to Palbociclib in Multiple Myeloma

Angelique Bruyer, Alboukadel Kassambara, PhD, Paul Anziani, Donia El Bahlagui, Nicolas Robert, Laure Vincent, MD, Bernard Klein, Jerome Moreaux, PhD

Blood (2016) 128 (22): 5666.

https://doi.org/10.1182/blood.V128.22.5666.5666

Published: 2016

Journal Articles

Limits of Phenotype Analyses in the Diagnosis of HbS Heterozygosity. Example of a Hb S Carrier Phenocopy Due to Hb Arya (Alpha 1: codon 47 Asp>Asn) and a Gene Conversion

Serge Pissard, MD PhD, Adrien Pecriaux, Catherine Paillard, MD PhD, Anne Galoisy, PharmD, Jean Riou, Nathalie Le Metayer, Henri Wajcman, MD PhD

Blood (2016) 128 (22): 4850.

https://doi.org/10.1182/blood.V128.22.4850.4850

Published: 2016

Journal Articles

Proteasome Inhibitor-Adapted Myeloma Cells That Lack Proteasome Gene Mutations Resist Highly Efficient Proteasome Inhibition and Show Proteomic Alterations That Suggest Complex Metabolic Changes

Lenka Besse, PhD, Guillem Soriano, Nan Li, Andrej Besse, Marianne Kraus, Juergen Bader, Tobias Christian Silzle, MD, Nico Meeuwenoord, Hans den Dulk, Herman S Overkleeft, Bogdan Florea, Christoph Driessen, MD

Blood (2015) 126 (23): 1278.

https://doi.org/10.1182/blood.V126.23.1278.1278

Published: 2015

Journal Articles

Creation of a Gene Expression Signature-Based Prediction Model Specific to Proteasome Inhibitor Response in Multiple Myeloma

Amit Kumar Mitra, PhD, Ujjal Mukherjee, PhD, Taylor Harding, Snigdhansu Chatterjee, PhD, Brian G Van Ness, PhD

Blood (2015) 126 (23): 3053.

https://doi.org/10.1182/blood.V126.23.3053.3053

Published: 2015

Journal Articles

Identification of a Gene Expression Signature Characterizing Clonal Fitness and Dominance in Vivo in a Murine Model of MLL-AF9 Leukemia

Francois Mercier, MD, Jiantao Shi, PhD, David Sykes, MDPhD, Youmna Sami Kfoury, PhD, Rushdia Z. Yusuf, MBBS, MPH, Elizabeth Miller, Radovan Vasic, Alex Zhu, Franziska Michor, PhD, Winston Hide, PhD, David T. Scadden, MD

Blood (2014) 124 (21): 2383.

https://doi.org/10.1182/blood.V124.21.2383.2383

Published: 2014

Journal Articles

Identifying a Gene Expression (GEP)-Based Model Predicting for Progression from AMM to Cmm Requiring Therapy in S0120 Patients Treated at Mirt

Rashid Z Khan, MD, Christoph Heuck, MD, Adam Rosenthal, Caleb K Stein, MS, Joshua Epstein, DSc, Shmuel Yaccoby, PhD, Xenofon Papanikolaou, MD, Yogesh Jethava, MB, MRCP, MD FRCPath, Maurizio Zangari, MD, Frits Van Rhee, Madhav V. Dhodapkar, MD, Gareth J Morgan, MD PhD, Antje Hoering, PhD, John Crowley, PhD, Bart Barlogie, MD PhD

Blood (2014) 124 (21): 2078.

https://doi.org/10.1182/blood.V124.21.2078.2078

Published: 2014

Journal Articles

Cellular Immune Responses To Vector In a Gene Therapy Trial For Hemophilia B Using An AAV8 Self-Complementary Factor IX Vector

Etiena Basner-Tschakarjan, MD PhD, Federico Mingozzi, PhD, Yifeng Chen, MD, Amit Nathwani, MD, PhD, Edward Tuddenham, MD, Anne Riddell, BSc, Catherine Ng, MS, Pradip Rustagi, MD, Bertil Glader, MD, PhD, Mark Kay, MD, PhD, Ulrike M. Reiss, MD, Arthur W. Nienhuis, MD, Andrew Davidoff, MD, Katherine A. High, MD

Blood (2013) 122 (21): 717.

https://doi.org/10.1182/blood.V122.21.717.717

Published: 2013

Journal Articles

Somatic Mutation of SF3B1 , a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts

Blood (2011) 118 (21): 3.

https://doi.org/10.1182/blood.V118.21.3.3

Published: 2011

Journal Articles

Identification of Rab5 as a Gene Involved in Chronic Myeloid Leukemia (CML) Progression.

Daniela Cilloni, MD, PhD, Monica Pradotto, PhD, Francesca Messa, PhD, Francesca Arruga, PhD, Enrico Bracco, PhD, Sonia Carturan, PhD, Chiara Maffè, PhD, Emanuela Messa, MD, Antonia Rotolo, MD, Elisabetta Greco, MD, Ilaria Iacobucci, PhD, Thea Kalebic, MD, Roberto Bernardoni, Fabrizio Pane, MD, Giovanni Martinelli, MD, Michele Baccarani, M.D., Giuseppe Saglio, MD

Blood (2009) 114 (22): 3470.

https://doi.org/10.1182/blood.V114.22.3470.3470

Published: 2009

Journal Articles

BTG1, a Gene Frequently Deleted in Pre-B ALL, Controls Glucocorticoid Receptor-Mediated Gene Expression.

Frank N. van Leeuwen, PhD, Joost Casper van Galen, PhD, Roland P. Kuiper, PhD, Liesbeth van Emst, Marloes R Levers, Esther Tijchon, Msc, Blanca Scheijen, Esmee Waanders, PhD, Simon V van Reijmersdal, Christian Gillissen, Msc., Ad Geurts van Kessel, Peter M. Hoogerbrugge

Blood (2009) 114 (22): 3458.

https://doi.org/10.1182/blood.V114.22.3458.3458

Published: 2009

Journal Articles

Significance of BAALC , MN 1, ERG , CEBP a Gene Expression as New Prognostic Factors, in the Context of Other Molecular Markers in Intermediate Risk AML Group According to Cytogenetics, Including Patients Younger Than 60 Years

Marta Antonina Libura, MD, PhD, Beata Piatkowska-Jakubas, Olga Haus, Izabela Florek, Bozena Jazwiec, PhD, Krystyna Soszynska, PhD, Zoriana Salamanchuk, PhD, Malgorzata Jakobczyk, Szymon Fornagiel, Tomasz Sacha, Marek Kielbinski, Kazimierz Kuliczkowski, Ewa Duszenko, Anna Jaskowiec, Barbara Mucha, Katarzyna Skonieczna, Aleksander Skotnicki

Blood (2008) 112 (11): 4855.

https://doi.org/10.1182/blood.V112.11.4855.4855

Published: 2008

Journal Articles

Pediatric Acute Myeloid Leukemia with Nucleophosmin Mutations Is Characterized by a Gene Expression Signature with Dysregulated HOX Gene Expression Distinct from MLL -Rearranged Leukemias.

Charles G. Mullighan, MBBS, MSc, MD, Alyssa L. Kennedy, BS, Xiaodong Zhou, MS, Sheila A. Shurtleff, PhD, James R. Downing, MD

Blood (2005) 106 (11): 2993.

https://doi.org/10.1182/blood.V106.11.2993.2993

Published: 2005

Journal Articles

TACI and BCMA, Unlike BAFF-R, Are Expressed by Human Myeloma Cell Lines and TACI + Cell Lines Have a Gene Signature Indicative of Mature Bone Marrow Plasma Cells and Bone Marrow Environment Dependence.

Jerome Moreaux, Friedrich W. Cremer, Thierry Reme, Karene Mahtouk, Veronique Pantesco, John de Vos, Marion Moos, Nicolas Robert, Hartmut Goldschmidt, Jean-François Rossi, Dirk Hose, Bernard Klein

Blood (2005) 106 (11): 3400.

https://doi.org/10.1182/blood.V106.11.3400.3400

Published: 2005

Journal Articles

EVI1, a Gene Frequently Involved in Myelodysplastic Syndrome, Causes an Erythroid Dysplasia in a Mouse Model with Conditional Transgene Expression.

Eric van den Akker, PhD, Dominik Spensberger, M.Sc., Antoinette Beijen, Kirsten van Lom, PhD, Claudia Erpelinck, Ruud Delwel, PhD

Blood (2004) 104 (11): 466.

https://doi.org/10.1182/blood.V104.11.466.466

Published: 2004

Journal Articles

EAR-2: Identification of a Gene Involved in Maintenance of Clonogenicity in Haematopoiesis.

Christine V. Ichim, MSc, Mahadeo A. Sukhai, MSc, J. Brandwein, MD, Mark D. Minden, MD, PhD, Aaron D. Schimmer, MD, PhD, Andre C. Schuh, MD, Suzanne Kamel-Reid, PhD, Norman N. Iscove, MD, PhD, Richard A. Wells, MD, DPhil

Blood (2004) 104 (11): 3226.

https://doi.org/10.1182/blood.V104.11.3226.3226

Published: 2004

Journal Articles

Intra-S-Phase Regulator cdc7 Is a Gene Target of the c-Myb Proto-Oncogene in Human Leukemias.

Susan E. Shetzline, Ph.D., June Hsu, B.A., Lindsay Thalheim, B.A., John K. Choi, M.D. Ph.D., Alan M. Gewirtz, M.D.

Blood (2004) 104 (11): 2039.

https://doi.org/10.1182/blood.V104.11.2039.2039

Published: 2004

Journal Articles

Cytokine Prestimulation as a Gene Therapy Strategy: Implications for Using the MDR1 Gene as a Dominant Selectable Marker

C. Anthony Blau, Tobias Neff, Thalia Papayannopoulou

Blood (1997) 89 (1): 146–154.

https://doi.org/10.1182/blood.V89.1.146

Published: 1997

NARROW

Variability in Killler Immunglobulin like Receptor Gene Expression As a Periodic Function of Gene Position on Chromosome 19

Identification of a Gene Signature Associated to Treatment Response to Palbociclib in Multiple Myeloma

Limits of Phenotype Analyses in the Diagnosis of HbS Heterozygosity. Example of a Hb S Carrier Phenocopy Due to Hb Arya (Alpha 1: codon 47 Asp>Asn) and a Gene Conversion

Proteasome Inhibitor-Adapted Myeloma Cells That Lack Proteasome Gene Mutations Resist Highly Efficient Proteasome Inhibition and Show Proteomic Alterations That Suggest Complex Metabolic Changes

Creation of a Gene Expression Signature-Based Prediction Model Specific to Proteasome Inhibitor Response in Multiple Myeloma

Identification of a Gene Expression Signature Characterizing Clonal Fitness and Dominance in Vivo in a Murine Model of MLL-AF9 Leukemia

Identifying a Gene Expression (GEP)-Based Model Predicting for Progression from AMM to Cmm Requiring Therapy in S0120 Patients Treated at Mirt

Cellular Immune Responses To Vector In a Gene Therapy Trial For Hemophilia B Using An AAV8 Self-Complementary Factor IX Vector

Somatic Mutation of SF3B1 , a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts

Identification of Rab5 as a Gene Involved in Chronic Myeloid Leukemia (CML) Progression.

BTG1, a Gene Frequently Deleted in Pre-B ALL, Controls Glucocorticoid Receptor-Mediated Gene Expression.

Significance of BAALC , MN 1, ERG , CEBP a Gene Expression as New Prognostic Factors, in the Context of Other Molecular Markers in Intermediate Risk AML Group According to Cytogenetics, Including Patients Younger Than 60 Years

Pediatric Acute Myeloid Leukemia with Nucleophosmin Mutations Is Characterized by a Gene Expression Signature with Dysregulated HOX Gene Expression Distinct from MLL -Rearranged Leukemias.

TACI and BCMA, Unlike BAFF-R, Are Expressed by Human Myeloma Cell Lines and TACI + Cell Lines Have a Gene Signature Indicative of Mature Bone Marrow Plasma Cells and Bone Marrow Environment Dependence.

EVI1, a Gene Frequently Involved in Myelodysplastic Syndrome, Causes an Erythroid Dysplasia in a Mouse Model with Conditional Transgene Expression.

EAR-2: Identification of a Gene Involved in Maintenance of Clonogenicity in Haematopoiesis.

Intra-S-Phase Regulator cdc7 Is a Gene Target of the c-Myb Proto-Oncogene in Human Leukemias.

Cytokine Prestimulation as a Gene Therapy Strategy: Implications for Using the MDR1 Gene as a Dominant Selectable Marker

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only